Enhance your practice with CME and tools that focus on the management of neurological conditions.
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Kaitlin Batley, MD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Ethan Meltzer, MD
Navigating Emerging Biomarkers in MS Care
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Discharge Planning After Myasthenic Crisis
Qihua Fan, MD
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
David Weisman, MD
Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Uncovering TK2d: How to Navigate Diagnostic Challenges
Exploring Genetic Links Between EBV Clearance and MS Risk
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
Precision Medicine for Myasthenia Gravis
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Navigating Emerging Treatment Options in MG
New Therapies, New Strategy: Rethinking MG Inpatient Care
More Than a Myopathy: The Lived Experience of TK2d
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.